NewzThe Confederation of Spanish Alzheimer's and other Dementias (CEAFA) has launched a signature collection campaign on the Change.org platform. The initiative urges the Spanish Ministry of Health to provide public funding for two Alzheimer's treatments that have been authorized within the European Union: lecanemab and donanemab.
This campaign targets national health authorities to ensure patient access to the newly approved therapeutics, highlighting the ongoing debate over the coverage and integration of advanced disease-modifying Alzheimer's therapies into public healthcare systems.
In-depth summary · AI, neutral